These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 751079)

  • 21. The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer.
    Kim MW; Kim WH; Wang HJ; Chung JB; Chun M
    Hepatogastroenterology; 2001; 48(41):1298-301. PubMed ID: 11677950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of photodynamic therapy in malignant lesions of stomach, bile duct, pancreas, colon and rectum.
    Wang JB; Liu LX
    Hepatogastroenterology; 2007; 54(75):718-24. PubMed ID: 17591048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thyroid diseases in sub-Saharan Africa].
    Sidibé el H
    Sante; 2007; 17(1):33-9. PubMed ID: 17897900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curative and palliative aspects of regional chemotherapy in combination with surgery.
    Müller H; Hilger R
    Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ
    Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicology and Carcinogenesis Studies of Furan (CAS No. 110-00-9) in F344 Rats and B6C3F1 Mice(Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Jan; 402():1-286. PubMed ID: 12621516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two cases of advanced extrahepatic bile duct cancer successfully treated by S-1 monotherapy].
    Ueno H; Ikeda M
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1311-4. PubMed ID: 17687221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical modulation of 5-FU--effect of low dose CDDP].
    Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Food groups and colorectal cancer risk.
    Levi F; Pasche C; La Vecchia C; Lucchini F; Franceschi S
    Br J Cancer; 1999 Mar; 79(7-8):1283-7. PubMed ID: 10098773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coffee consumption and the risk of breast cancer.
    Tavani A; Pregnolato A; La Vecchia C; Favero A; Franceschi S
    Eur J Cancer Prev; 1998 Feb; 7(1):77-82. PubMed ID: 9511854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary cancer and prevention using antimutagens.
    Ferguson LR; Philpott M; Karunasinghe N
    Toxicology; 2004 May; 198(1-3):147-59. PubMed ID: 15138038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
    Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.
    Liu B; Hervé J; Bioulac-Sage P; Valogne Y; Roux J; Yilmaz F; Boisgard R; Guettier C; Calès P; Tavitian B; Samuel D; Clerc J; Bréchot C; Faivre J
    Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholangiocarcinoma.
    Mosconi S; Beretta GD; Labianca R; Zampino MG; Gatta G; Heinemann V
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):259-70. PubMed ID: 18977670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum determination of CA 19-9 in patients with digestive cancers and its diagnostic evaluation].
    Arakawa Y; Kobayashi H; Ozaki T; Ariga H; Matsuo Y; Honda T; Arai T; Kurosu Y; Morita K; Konuma H
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):917-25. PubMed ID: 6586110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of carcinoma with congenital cystic conditions of the liver and bile ducts.
    Bloustein PA
    Am J Gastroenterol; 1977 Jan; 67(1):40-6. PubMed ID: 851104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.